Jul 1, 1975

Cordaron and nonachlasine in treatment of chronic coronary insufficiency

V I MetelitsaV P Lupanov


In a double blind study of the clinical effect of Cordaron conducted in 55 patients with chronic ischaemic heart disease a positive effect was obtained in 80.4% of the cases, an effect of placebo-in 24.3%. Cordaron was especially effective in patients with localized stenoses of the coronary arteries. Nonachlasine (an activator of the cardiac beta-adrenergic receptors) proved effective in 10 of 13 patients with chronic ischaemic heart disease.

  • References
  • Citations


  • We're still populating references for this paper, please check back later.
  • References
  • Citations


  • This paper may not have been cited yet.

Mentioned in this Paper

Chronic Disease
Amiodarone hydrochloride
Adrenergic beta-Agonists
Chronic Coronary Insufficiency
Drug Evaluation
Beta-adrenergic receptor
Coronary Artery
Chronic Myocardial Ischemia
Clinical Trials
Procedures on Coronary Arteries

About this Paper

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.